AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice
Authors:
- Catherine CailletCatherine Caillet
- Fabienne PirasFPFabienne Piras
- 1 April 2010
- Vol. 28 (18) , 3076-3079
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trialsThe Lancet, 2010
- Response to a Monovalent 2009 Influenza A (H1N1) VaccineNew England Journal of Medicine, 2009
- Adjuvant is necessary for a robust immune response to a single dose of H1N1 pandemic flu vaccine in micePLoS Currents, 2009
- Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008–2009 conventional influenza vaccineVaccine, 2009
- Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in HumansScience, 2009
- Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: Effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge modelVaccine, 2008
- FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10–11, 2007Vaccine, 2008
- Effect of priming on subsequent response to inactivated influenza vaccineVaccine, 2002
- Immunopotentiation of humoral and cellular responses to inactivated influenza vaccines by two different adjuvants with potential for human useVaccine, 1998
- Immunogenicity and Reactogenicity of Influenza A/New Jersey/76 Virus Vaccines in Normal AdultsThe Journal of Infectious Diseases, 1977